NEW YORK (GenomeWeb News) – Cellular Dynamics International today said that the National Institutes of Health Center for Regenerative Medicine has awarded it a contract for up to $7 million over three years to provide human induced pluripotent stem cell lines and terminally differentiated tissue cells from normal or specified patient populations.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.